Description: 

Each session of this neurology oncology case conference reviews 4-5 challenging or unique cases, presented by the providers involved, with comprehensive details including relevant labs, diagnostic imaging, patient history, and other key factors. During a roundtable discussion, the team collaborates to determine the need for further diagnostic testing, establish the most likely diagnoses or differential diagnoses, and evaluate best practice management strategies for each case. Many cases also offer opportunities to explore emerging evidence in neurology oncology, including innovative treatments and approaches to complex neurological conditions. Additionally, the conference provides a platform for discussing cultural, ethnic, and age-related considerations that may influence patient care. This case-based approach fosters the development of clinical competence, enhances team performance in managing complex cases, and promotes culturally sensitive care free from implicit biases.

Target Audience: 

Physicians (MD or DO)

Other healthcare professionals

Learning Objectives: 

After Attending This Activity Learners Should Be Able To:

1. Coordinate care effectively as a team for patients with challenging neurological cancers and diseases.

2. Review the most current standards of care for the treatment of neurological cancers and diseases.

3. Evaluate the outcomes of surgery and radiation therapy in the treatment of neurological cancers and diseases.

Providing Culturally Appropriate Care which is Free of Implicit Biases (AB 1195 & 241):

Learners are strongly encouraged to engage in self-directed learning related to the impact of implicit biases in this clinical area via the references provided below:

  •  
  • Social Determinants of Health (SDOH)/Cultural or Linguistic Considerations:
    • Zettler ME, Feinberg BA, Jeune-Smith Y, Gajra A. Impact of social determinants of health on cancer care: a survey of community oncologists. BMJ Open. 2021 Oct 6;11(10):e049259. doi: 10.1136/bmjopen-2021-049259. PMID: 34615676; PMCID: PMC8496396. - LINK TO ARTICLE
  • Implicit Bias Considerations (as it relates to the content):                                                                                    
    • Kumthekar P, Dunbar EM, Peters KB, Brastianos PK, Porter AB. A broad perspective on evaluating bias in the neuro-oncology workplace. Neuro Oncol. 2021 Mar 25;23(3):498-499. doi: 10.1093/neuonc/noaa286. PMID: 33547796; PMCID: PMC7992888 - LINK TO ARTICLE

Disclosure of Financial or In-Kind Commercial Support & Conflict of Interest

No one involved in the planning or presentation of this educational activity have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. No financial or in-kind commercial support was received to produce or promote this educational activity.   

– Provider Designee/Verification: Fozia Ferozali, Ed.D. 

Faculty List: 

Planner(s)

Pauling Chang, Diplomate, American Board of Radiology, Radiation Oncology has no relevant financial relationships to disclose at this time.

Anne Geluz has no relevant financial relationships to disclose at this time.

Speaker(s)

Pauling Chang, Diplomate, American Board of Radiology, Radiation Oncology has no relevant financial relationships to disclose at this time.

Sharon Dutton, MD, MPH, FACR has no relevant financial relationships to disclose at this time.

Paul Jackson, MD, PhD has no relevant financial relationships to disclose at this time.

Robert Lundahl  has no relevant financial relationships to disclose at this time.

Stephen Ryu has no relevant financial relationships to disclose at this time.

Gordon Sakamoto has no relevant financial relationships to disclose at this time.

Daniel Schiffner, MD has no relevant financial relationships to disclose at this time.

Al Taira, MD, ABR board certified Radiation Oncology has no relevant financial relationships to disclose at this time.

Session date: 
09/02/2026 - 12:30pm to 1:30pm PDT
Location: 
Radiation Oncology Conference Room
795 El Camino Real
Palo Alto, CA 94301
United States
See map: Google Maps
Add to calendar: 
  • 1.00 ABS MOC

    American Board of Surgery (ABS)

    Successful completion of this CME activity, [which includes participation in the evaluation component], enables the learner to earn credit toward the CME [and Self-Assessment] requirement(s) of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

  • 1.00 AMA PRA Category 1 Credit™

    Physician Credit 

    Sutter Health designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™ for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

     

  • 1.00 Non-Physician Participation Credit

    Sutter Health designates this Live activity for a maximum of 1.00 Non-Physician Participation Credit. Non-Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    AMA PRA Category 1 Credits HOURS™ Continuing Medical Education is acceptable for meeting the continuing education requirements for Pharmacists, Physician Assistants, Psychologists, Registered Nurses, and Respiratory Care Practitioners. For other disciplines, please check with the regulatory board for your discipline to confirm what type of credits meet the continuing education requirements. Continuing education hours for nurses accredited by ANCC, via Joint Accreditation.

     

Please login or register to take this course.